Stocktwits on MSN
Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study
The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback